EUVIMEDEUVIMED entdecken
Open Access

Structural mechanisms of SAMD9 autoinhibition and pathogenic dysregulation

Zongjun Mou iD, Fushun Zhang iD, Marisol Morales iD, Bibekananda Sahoo iD, Xinghong Dai iD, Yan Xiang iD

Science Advances · 25.09.2026 · 12 (39)

DOI: 10.1126/sciadv.aeg3967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 25.09.2026. Verfasst von Zongjun Mou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SAMD9 and SAMD9L (SAMD9/9L) are large cytosolic proteins essential for hematopoietic homeostasis and antiviral defense ( 1 – 3 ). Germline gain-of-function (GoF) mutations in SAMD9/9L cause severe multisystem disorders and predispose to leukemia, but the mechanisms that regulate SAMD9/9L activity and how pathogenic mutations disrupt these processes remain poorly understood. Here, we report cryo–electron microscopy structures of human SAMD9 in multiple conformational and oligomeric states. SAMD9 predominantly adopts a closed, autoinhibited conformation stabilized by a central ATP-bound nucleotide-binding oligomerization domain (NOD) and an extensive network of intramolecular interactions. Recurrent patient-derived GoF mutations localize to and destabilize these intramolecular interfaces, whereas structure-guided compensatory mutations that restabilize these interfaces restore autoinhibition. We further identify low-abundance asymmetric SAMD9 dimers in which one protomer undergoes large conformational changes and establishes intermolecular interactions that are essential for SAMD9 activation. Together, these findings define the structural basis of SAMD9 autoinhibition and reveal how human GoF mutations disrupt this regulatory mechanism to drive disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor ProteinsAdaptor Proteins, Signal TransducingHumansMutationCryoelectron MicroscopyModels, MolecularProtein ConformationProtein MultimerizationProtein BindingIntracellular Signaling Peptides and Proteins

Substanzen

SAMD9 protein, humanTumor Suppressor ProteinsAdaptor Proteins, Signal TransducingSAMD9L protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Department of Microbiology, Immunology and Molecular Genetics, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Antonio, San Antonio, TX 78229, USA.

ORCID-Profile: Zongjun Mou, Fushun Zhang, Marisol Morales, Bibekananda Sahoo, Xinghong Dai, Yan Xiang

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Mou, Z., Zhang, F., Morales, M., Sahoo, B., Dai, X., & Xiang, Y. (2026). Structural mechanisms of SAMD9 autoinhibition and pathogenic dysregulation. Science Advances, 12(39). https://doi.org/10.1126/sciadv.aeg3967

Vancouver

Mou Z, Zhang F, Morales M, Sahoo B, Dai X, Xiang Y. Structural mechanisms of SAMD9 autoinhibition and pathogenic dysregulation. Science Advances. 2026;12(39). doi:10.1126/sciadv.aeg3967

BibTeX
@article{Mou2026,
  author = {Mou, Zongjun and Zhang, Fushun and Morales, Marisol and Sahoo, Bibekananda and Dai, Xinghong and Xiang, Yan},
  title = {Structural mechanisms of SAMD9 autoinhibition and pathogenic dysregulation},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {39},
  doi = {10.1126/sciadv.aeg3967}
}
Kostenlos starten →